Conference
An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival.
Authors
Ung Y; Gu C; Cline K; Sun A; MacRae RM; Wright JR; Yu E; Ehrlich L; Gulenchyn KY; Shulman H
Volume
29
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
May 20, 2011
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X